CN203342531U - Plasma concentration system - Google Patents
Plasma concentration system Download PDFInfo
- Publication number
- CN203342531U CN203342531U CN 201320356390 CN201320356390U CN203342531U CN 203342531 U CN203342531 U CN 203342531U CN 201320356390 CN201320356390 CN 201320356390 CN 201320356390 U CN201320356390 U CN 201320356390U CN 203342531 U CN203342531 U CN 203342531U
- Authority
- CN
- China
- Prior art keywords
- concentration
- pump
- unit group
- upgrading unit
- blood plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
The utility model discloses a plasma concentration system which comprises a charging bucket, a first pump and a security filter, wherein an input end of the first pump is connected with an output end of the charging bucket; an output end of the first pump is connected with an input end of the security filter; an output end of the security filter is connected with an input end of a concentration unit group; the concentration unit group at least comprises two concentration units; and a concentration solution outlet of the concentration unit group is connected with a spray drying device. In this case, animal plasma is directly subjected to multistage concentration by the concentration unit group, discharged from the concentration solution outlet of the concentration unit group, and subjected to spray drying; compared with the prior art, with the adoption of a working mode of continuous feeding and discharging, the concentration time is saved effectively; the production efficiency is improved; blocking to the security filter and membrane components of the concentration system due to circulation and concentration of the plasma is avoided; and the operation stability and reliability of the system are improved effectively.
Description
Technical field
The utility model relates to chemical technology field, is specifically related to a kind of concentration systems of blood plasma.
Background technology
Contain the bioactivators such as rich in protein, enzyme, vitamin in animal blood plasma, can be used for producing multiple biochemical product, be used widely in food, medicine and feed processing and other fields etc.Due to the water content of animal blood plasma, up in 93% left and right, therefore before preparing biochemical product, need it is carried out to concentrate drying, to reach the purpose that reduces reagent consumption and energy resource consumption.At present, it is mainly the circulation concentration systems that adopts batch-type, utilize ultrafiltration or nanofiltration to be concentrated animal blood plasma, then make SDPP by spray-drying, but while adopting the concentrated blood plasma of circulation concentration systems of batch-type, the fresh plasma of each batch is concentrated to interrupt, and every batch of blood plasma all adopts circulation concentrated, process time is long, efficiency is low, moreover, the anti-coagulants be accompanied by concentration process in blood plasma runs off, make the celloglobulin in blood plasma separate out, the cartridge filter that causes circulating in concentration systems, the membrane module of upgrading unit easily stops up, not only cause the interruption of production technology, also can affect effect and the service life of system equipment.
Summary of the invention
The purpose of this utility model is to provide a kind of efficient, the plasma extraction system that stable, reliability is high.
For achieving the above object, the technical solution adopted in the utility model is: a kind of concentration systems of blood plasma, comprise batch can, the first pump and cartridge filter, the input of described the first pump connects the output of batch can, the first delivery side of pump connects the input of cartridge filter, it is characterized in that: the output of described cartridge filter connects the input of upgrading unit group, and described upgrading unit group at least consists of two upgrading units, and the concentrated solution outlet of upgrading unit group is connected with spray-drying installation.
The beneficial effect that technique scheme produces is: animal blood plasma directly carries out multistage concentrated by the upgrading unit group, then discharge and carry out spray-drying from the concentrated solution outlet of upgrading unit group, than prior art, compare, the utility model adopts the mode of operation of continuous feed, discharging, effectively save concentration time, enhance productivity, simultaneously, the obstruction that the concentrated blood plasma of avoiding circulating causes the membrane module of cartridge filter and concentration systems, effectively improve stability and the reliability of device operation.
The accompanying drawing explanation
Fig. 1 is structural representation of the present utility model.
The specific embodiment
A kind of concentration systems of blood plasma, comprise batch can 10, the first pump 20 and cartridge filter 30, the input of described the first pump 20 connects the output of batch can 10, the output of the first pump 20 connects the input of cartridge filter 30, the output of described cartridge filter 30 connects the input of upgrading unit group, described upgrading unit group at least consists of two upgrading units, and the concentrated solution outlet of upgrading unit group is connected with spray-drying installation.Operation principle of the present utility model is: animal blood plasma is dropped in batch can 10, be delivered to cartridge filter 30 through the first pump 20 and carry out primary filter, to hold back particle larger in blood plasma, guarantee the safe operation of the upgrading unit group of postorder, the blood plasma leached through cartridge filter 30 enters the upgrading unit group and directly carries out multistage concentrated, then discharge and carry out spray-drying from the concentrated solution outlet of upgrading unit group, thickening efficiency according to blood plasma, can add continuously fresh blood plasma in batch can 10 according to certain speed, with guarantee concentration technology continue carry out.Compared with prior art, the utility model adopts the mode of operation of continuous feed, discharging, namely cancel in prior art and concentrate is got back in batch can to the technique that loops secondary concentration, and employing directly enters secondary after elementary concentrating, three inferior upgrading units are concentrated, entering spray-drying after the blood plasma continuous discharge concentrated gets final product, effectively save concentration time, enhance productivity, simultaneously, the obstruction that the concentrated blood plasma of avoiding circulating causes the membrane module of cartridge filter and concentration systems, effectively improve stability and the reliability of device operation.
As further preferred version: as shown in Figure 1, described upgrading unit group comprises elementary upgrading unit 40 and secondary upgrading unit 50, elementary upgrading unit 40 comprises the second pump 41 and elementary concentrated film device 42, secondary upgrading unit 50 comprises the 3rd pump 51 and the concentrated film device 52 of secondary, the input of described the second pump 41 is connected with the output of cartridge filter 30, the output of the second pump 41 is connected with the input of elementary concentrated film device 42, the input of described the 3rd pump 51 is connected with the elementary concentrated solution outlet 421 of elementary concentrated film device 42, the output of the 3rd pump 51 is connected with the input of the concentrated film device 52 of secondary, the secondary concentrated solution outlet 521 of the concentrated film device 52 of described secondary is connected with spray-drying installation, that is to say that each upgrading unit comprises pump and concentrated film device, delivery side of pump is connected with the input of concentrated film device, there is certain pressure while making blood plasma enter concentrated film device, guarantee the concentrated speed of blood plasma and the stable operation of concentration systems.
Further, elementary filtrate (liquid 422 and the secondary filtrate (liquid 522 of described upgrading unit group lead to collection processing system implementing, and as shown in Figure 1, elementary filtrate and secondary filtrate are collected and flowed to same pipeline, facilitate like this centralized collection of filtrate to process, improve process efficiency.
Further, the filtering accuracy of described cartridge filter 30 is 5～50 μ m, can and clean suspended particulate larger in the water of concentration systems, colloid, microorganism etc. by blood plasma like this is trapped in the cartridge surface and hole of cartridge filter 30, for the stable operation of postorder upgrading unit group is given security, avoid the membrane component in the upgrading unit group to stop up simultaneously, be conducive to extend the service life of membrane component.
Further, the NF membrane that membrane component in described upgrading unit group is rolling, the NF membrane of rolling is directly bought and is got final product on market, the convenient realization, according to the physicochemical property of blood plasma, the molecular cut off of the membrane component in preferred described upgrading unit group is 200-500D.
Claims (6)
1. the concentration systems of a blood plasma, comprise batch can (10), the first pump (20) and cartridge filter (30), the input of described the first pump (20) connects the output of batch can (10), the output of the first pump (20) connects the input of cartridge filter (30), it is characterized in that: the output of described cartridge filter (30) connects the input of upgrading unit group, described upgrading unit group at least consists of two upgrading units, and the concentrated solution outlet of upgrading unit group is connected with spray-drying installation.
2. the concentration systems of blood plasma according to claim 1, it is characterized in that: described upgrading unit group comprises elementary upgrading unit (40) and secondary upgrading unit (50), elementary upgrading unit (40) comprises the second pump (41) and elementary concentrated film device (42), secondary upgrading unit (50) comprises the 3rd pump (51) and the concentrated film device (52) of secondary, the input of described the second pump (41) is connected with the output of cartridge filter (30), the output of the second pump (41) is connected with the input of elementary concentrated film device (42), the input of described the 3rd pump (51) is connected with the elementary concentrated solution outlet (421) of elementary concentrated film device (42), the output of the 3rd pump (51) is connected with the input of the concentrated film device (52) of secondary, the secondary concentrated solution outlet (521) that described secondary concentrates film device (52) is connected with spray-drying installation.
3. the concentration systems of blood plasma according to claim 2, it is characterized in that: elementary filtrate (liquid (422) and the secondary filtrate (liquid (522) of described upgrading unit group lead to collection processing system implementing.
4. according to the concentration systems of claim 1 or 2 described blood plasma, it is characterized in that: the filtering accuracy of described cartridge filter (30) is 5～50 μ m.
5. according to the concentration systems of claim 1 or 2 described blood plasma, it is characterized in that: the NF membrane that the membrane component in described upgrading unit group is rolling.
6. according to the concentration systems of claim 1 or 2 described blood plasma, it is characterized in that: the molecular cut off of the membrane component in described upgrading unit group is 200-500D.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201320356390 CN203342531U (en) | 2013-06-20 | 2013-06-20 | Plasma concentration system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201320356390 CN203342531U (en) | 2013-06-20 | 2013-06-20 | Plasma concentration system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203342531U true CN203342531U (en) | 2013-12-18 |
Family
ID=49742473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201320356390 Expired - Lifetime CN203342531U (en) | 2013-06-20 | 2013-06-20 | Plasma concentration system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203342531U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103316538A (en) * | 2013-06-20 | 2013-09-25 | 安徽普朗膜技术有限公司 | Concentrating system for plasma |
| CN104447983A (en) * | 2014-12-23 | 2015-03-25 | 扬州大学 | Method for classifying and extracting active components of deer blood |
-
2013
- 2013-06-20 CN CN 201320356390 patent/CN203342531U/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103316538A (en) * | 2013-06-20 | 2013-09-25 | 安徽普朗膜技术有限公司 | Concentrating system for plasma |
| CN103316538B (en) * | 2013-06-20 | 2015-11-18 | 安徽普朗膜技术有限公司 | The concentration systems of blood plasma |
| CN104447983A (en) * | 2014-12-23 | 2015-03-25 | 扬州大学 | Method for classifying and extracting active components of deer blood |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463986B (en) | The dull and stereotyped permeable membrane device of a kind of dielectrophoresis | |
| CN101870722A (en) | Process for concentrating protein in soy protein wastewater by two-stage foam separation method | |
| CN203342531U (en) | Plasma concentration system | |
| CN202265462U (en) | Energy recovery and desalination system by plunger pump | |
| CN103316538B (en) | The concentration systems of blood plasma | |
| CN201343455Y (en) | Wastewater treatment system with metallic ion | |
| CN203353611U (en) | Soy sauce filtering system | |
| CN202226858U (en) | Purification and concentration device of virus liquid | |
| CN202465408U (en) | System for concentrating and recycling residual polyethyleneglycol in condensation waste water | |
| CN202089806U (en) | Water-saving and energy-saving reverse-osmosis device | |
| CN200948412Y (en) | Special type electrically driven film separating device | |
| CN212293063U (en) | Apramycin waste water concentration system | |
| CN203829785U (en) | Plasma concentrating system | |
| CN205838756U (en) | The dense Water Sproading of integrated reverse osmosis utilizes equipment | |
| CN203498176U (en) | Treatment system for treating electroplating acid copper waste water | |
| CN205023982U (en) | Acid -base regenerating unit of quick continuous type | |
| CN202087240U (en) | Membrane separation device | |
| CN203002218U (en) | Reverse osmosis (RO) water purifying plant | |
| CN203960101U (en) | The concentration systems of inulin liquid glucose | |
| CN104096480B (en) | The high power enrichment facility of high efficiency low energy consumption and the method for feed liquid process thereof | |
| CN214862548U (en) | High-pressure nanofiltration membrane system for purifying and concentrating iso-VC stock solution | |
| CN204051171U (en) | A kind of water reducer mother liquor filters purification process units | |
| CN204752479U (en) | A waste water recycle system for in alkali production | |
| CN212369936U (en) | Ceramic membrane filtration system for purifying vitamin C | |
| CN202766449U (en) | Device of protein recycling from potato starch production waste liquor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20131218 |
|
| CX01 | Expiry of patent term |